PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZBH vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ZBH and JNJ is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

ZBH vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-0.25%
-3.18%
ZBH
JNJ

Key characteristics

Sharpe Ratio

ZBH:

-0.44

JNJ:

-0.35

Sortino Ratio

ZBH:

-0.48

JNJ:

-0.41

Omega Ratio

ZBH:

0.94

JNJ:

0.95

Calmar Ratio

ZBH:

-0.24

JNJ:

-0.31

Martin Ratio

ZBH:

-0.64

JNJ:

-0.79

Ulcer Index

ZBH:

15.01%

JNJ:

6.88%

Daily Std Dev

ZBH:

21.72%

JNJ:

15.48%

Max Drawdown

ZBH:

-65.03%

JNJ:

-52.60%

Current Drawdown

ZBH:

-34.87%

JNJ:

-14.32%

Fundamentals

Market Cap

ZBH:

$21.20B

JNJ:

$353.99B

EPS

ZBH:

$5.24

JNJ:

$6.04

PE Ratio

ZBH:

20.33

JNJ:

24.34

PEG Ratio

ZBH:

1.40

JNJ:

0.86

Total Revenue (TTM)

ZBH:

$5.66B

JNJ:

$66.30B

Gross Profit (TTM)

ZBH:

$3.63B

JNJ:

$45.96B

EBITDA (TTM)

ZBH:

$1.81B

JNJ:

$22.61B

Returns By Period

In the year-to-date period, ZBH achieves a 3.72% return, which is significantly higher than JNJ's 1.67% return. Over the past 10 years, ZBH has underperformed JNJ with an annualized return of 0.54%, while JNJ has yielded a comparatively higher 6.72% annualized return.


ZBH

YTD

3.72%

1M

3.73%

6M

-0.41%

1Y

-10.76%

5Y*

-4.71%

10Y*

0.54%

JNJ

YTD

1.67%

1M

1.58%

6M

-3.46%

1Y

-5.91%

5Y*

2.52%

10Y*

6.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZBH vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH
The Risk-Adjusted Performance Rank of ZBH is 2525
Overall Rank
The Sharpe Ratio Rank of ZBH is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 2020
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 2020
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 3333
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2626
Overall Rank
The Sharpe Ratio Rank of JNJ is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 2222
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 2323
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2828
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZBH vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZBH, currently valued at -0.44, compared to the broader market-2.000.002.004.00-0.44-0.35
The chart of Sortino ratio for ZBH, currently valued at -0.48, compared to the broader market-4.00-2.000.002.004.00-0.48-0.41
The chart of Omega ratio for ZBH, currently valued at 0.94, compared to the broader market0.501.001.502.000.940.95
The chart of Calmar ratio for ZBH, currently valued at -0.24, compared to the broader market0.002.004.006.00-0.24-0.31
The chart of Martin ratio for ZBH, currently valued at -0.64, compared to the broader market-10.000.0010.0020.00-0.64-0.79
ZBH
JNJ

The current ZBH Sharpe Ratio is -0.44, which is comparable to the JNJ Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of ZBH and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.44
-0.35
ZBH
JNJ

Dividends

ZBH vs. JNJ - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 0.88%, less than JNJ's 3.34% yield.


TTM20242023202220212020201920182017201620152014
ZBH
Zimmer Biomet Holdings, Inc.
0.88%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%0.78%
JNJ
Johnson & Johnson
3.34%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

ZBH vs. JNJ - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for ZBH and JNJ. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-34.87%
-14.32%
ZBH
JNJ

Volatility

ZBH vs. JNJ - Volatility Comparison

Zimmer Biomet Holdings, Inc. (ZBH) has a higher volatility of 5.73% compared to Johnson & Johnson (JNJ) at 5.21%. This indicates that ZBH's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
5.73%
5.21%
ZBH
JNJ

Financials

ZBH vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab